Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Clinical Pharmacy and Pharmacology | JAMA – JAMA Network October 5, 2023
EMA statement on ongoing review of GLP-1 receptor agonists | European Medicines Agency – European Medicines Agency | July 11, 2023